SCHEMBL13588554

SCHEMBL13588554

CC(C)[C@H](C(=O)NCCO)C(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 2/20 0.42
CYP3A4 P08684 1/20 0.42
PTGS1 P23219 1/20 0.42
KCNH2 Q12809 1/20 0.42
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CNR1 P21554 2/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
ECE1 P42892 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5537815 1.00 USP2 (0.50) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12884386 0.88 PTGS1 (0.56) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12884381 0.83 KDM4C (0.41) USP2MEN1KMT2ATSHRPTGS1
SCHEMBL24138419 0.82 CA1 (0.39) USP2MEN1KMT2ATSHRPTGS1
SCHEMBL14108224 0.81 USP2 (0.52) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12884526 0.80 DPP7 (0.44) USP2PTGS1KCNH2SMN1; SMN2
SCHEMBL24138129 0.80 HPGD (0.44) MEN1KMT2AALDH1A1PTGS1KCNH2
SCHEMBL13588550 0.79 POLB (0.44) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12884383 0.79 POLB (0.44) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL13588553 0.79 ECE1 (0.47) USP2MEN1KMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES PFIZER INC 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES TRPV1, CNR1, CNR2 USP2 4131/4885MEN1 2819/4885KMT2A 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.